Overview

Combination Chemotherapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer or Primary Peritoneal Cancer

Status:
Completed

Trial end date:
2013-01-28

Target enrollment:

Participant gender:

Summary

Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. It is not yet known which combination chemotherapy regimen is most effective in treating ovarian epithelial cancer and peritoneal cancer. Randomized phase III trial to compare the effectiveness of various combination chemotherapy regimens in treating patients who have stage III or stage IV ovarian cancer or primary peritoneal cancer.

Phase:

Phase 3

Details

Lead Sponsor:

Gynecologic Oncology Group

Collaborators:

Medical Research Council
National Cancer Institute (NCI)
Southwest Oncology Group

Treatments:

Albumin-Bound Paclitaxel
Carboplatin
Doxorubicin
Gemcitabine
Liposomal doxorubicin
Paclitaxel
Topotecan